Tool-Rich, Value-Constrained: Why pharma supply chains are still struggling to translate digital maturity into resilience, speed, and control

In our latest report, we explore why operational maturity has become the next critical challenge for the industry.

Key findings include:

• Only 11.7% of organisations describe their intervention model as preventive and risk-prioritised
• Just 3.3% have achieved network-based collaboration supported by shared standards
• Most organisations require 48–72 hours or longer to redesign and approve alternative transport routes during disruptions
• Fragmented coordination and cross-functional decision-making remain major barriers to rapid response

If your organisation is investing in visibility, digitalisation and supply chain resilience, this report provides a valuable benchmark against the wider pharmaceutical industry.

Access your copy!